Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03056846 · ClinicalTrials.gov registry record · NA
Probiotics on Stress-associated Gastrointestinal Function in University Students
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 634
- Enrollment target
NCT03056846: Completed NA study, sponsored by University of Florida.
NCT03056846 is a NA study that has completed, run by University of Florida. The registered enrollment target is 634 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03056846, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 634 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate the effect of a daily supplement of probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, Bifidobacterium longum MM-2) on stress-associated gastrointestinal function in university students during the time of semester exams.
Primary Outcome
Weekly GSRS constipation symptom score in probiotic mixture vs. individual probiotic vs. placebo
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Probiotic Combination
- DIETARY_SUPPLEMENT Bifidobacterium bifidum
- DIETARY_SUPPLEMENT Bifidobacterium longum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 634 participants |
| Start Date | 2017-09-05 |
| Est. Completion | 2018-02-05 |
| Phase | NA |
What the finished NCT03056846 record still lists
NCT03056846 is an interventional study that assigns participants to a tested intervention. The registered 634 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT03056846 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03056846 about?
NCT03056846 is a clinical study titled "Probiotics on Stress-associated Gastrointestinal Function in University Students". The purpose of this research study is to evaluate the effect of a daily supplement of probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, Bifidobacterium longum MM-2) on stress-associated gastrointestinal function in university students during the time of semester exams.
What is the current status of trial NCT03056846?
This trial is currently completed. It is a NA study. The enrollment target is 634 participants. The study started on 2017-09-05. Estimated completion is 2018-02-05.
What interventions are being tested in trial NCT03056846?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Probiotic Combination (DIETARY_SUPPLEMENT), Bifidobacterium bifidum (DIETARY_SUPPLEMENT), Bifidobacterium longum (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03056846?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03056846's enrollment target sits among peer trials
634 158th of 2000 higher than 1,842 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573027 · 634 participants · NA
Heart Disease of the Small Arteries in Women and Men
- NCT04108156 · 634 participants · Phase 3
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
- NCT07237295 · 634 participants · NA
CommunityRx-Kidney Health
- NCT03478826 · 635 participants
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI